FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

G & W Laboratories Ciclopirox Olamine Cream Recall

Ciclopirox Olamine Cream USP, 0

G & W Laboratories, Inc. · South Plainfield, NJ

Risk level
Class III
Reported by FDA
Apr 12, 2017
Recall ID
D-0636-2017
Check your lot numberHow we source this data

Summary

G & W Laboratories recalled Ciclopirox Olamine Cream starting Mar 20, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0636-2017 on Apr 12, 2017. Reason: Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.

Product description

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDC 0713-0638-31), and c) 90 g tubes (NDC 0713-0638-18), Rx only, Manufactured by: G&W Laboratories, Inc., South Plainfeld, NJ 07080.

Lot numbers, UPCs & expiration codes

Lot #: a) 63800090, Exp 04/17; 63800095, Exp 11/17; 1000573, Exp 02/18; 1002560, Exp 06/18; b) 63800090, Exp 04/17; 63800092, Exp 07/17; 63800093, Exp 08/17; 63800095, Exp 11/17; 1000574, Exp 02/18; 1001772, Exp 05/18; c) 63800089, Exp 03/17; 63800091, Exp 07/17; 63800094, Exp 08/17; 1000842, Exp 01/18; 1000966, Exp 03/18; 1001771, Exp 05/18; 1002562, Exp 06/18.

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0636-2017
Classification
Class III
Status
Terminated
Recall initiated
Mar 20, 2017
FDA report date
Apr 12, 2017
Quantity
230,700 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
G & W Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0636-2017, exactly as published.

Show all FDA fields
City
South Plainfield
State
NJ
Status
Terminated
Country
United States
Event ID
76767
Address
111 Coolidge St
Code information
Lot #: a) 63800090, Exp 04/17; 63800095, Exp 11/17; 1000573, Exp 02/18; 1002560, Exp 06/18; b) 63800090, Exp 04/17; 63800092, Exp 07/17; 63800093, Exp 08/17; 63800095, Exp 11/17; 1000574, Exp 02/18; 1001772, Exp 05/18; c) 63800089, Exp 03/17; 63800091, Exp 07/17; 63800094, Exp 08/17; 1000842, Exp 01/18; 1000966, Exp 03/18; 1001771, Exp 05/18; 1002562, Exp 06/18.
Postal code
07080-3895
Report date
Apr 12, 2017
Product type
Drugs
Recall number
D-0636-2017
Classification
Class III
Recalling firm
G & W Laboratories, Inc.
Product quantity
230,700 tubes
Termination date
Feb 14, 2018
Reason for recall
Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDC 0713-0638-31), and c) 90 g tubes (NDC 0713-0638-18), Rx only, Manufactured by: G&W Laboratories, Inc., South Plainfeld, NJ 07080.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Mar 20, 2017
Initial firm notification
E-Mail
Center classification date
Apr 4, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0636-2017, published Apr 12, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls